|
|
| Research article summary (published 30 Aug 2005): |
|
Free Full Text! See links below |
Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD.
Full Abstract
OBJECTIVE: Attention deficit hyperactivity disorder (ADHD) is a costly public health problem. To the authors' knowledge, this is the first study on the cost-effectiveness of the major forms of ADHD treatments used in NIMH's Multimodal Treatment Study of Children With ADHD (MTA Study). METHOD: Five hundred seventy-nine children with ADHD, combined type, ages 7 to 9.9, were assigned to 14 months of medication management, behavioral treatment, both combined, or community care. Services were tallied throughout the study, including medication, health care visits, behavioral treatments, and rental costs. Provider specialty, total time, and number of visits with providers were used to calculate costs, adjusted to FY 2000 dollars with the consumer price index. RESULTS: Treatment costs varied fourfold, with medication management being the least expensive, followed by behavioral treatment, and then combined treatment. Lower costs of medication treatment were found in the community care group, reflecting the less intensive (and less effective) nature of community-delivered treatment. Medical management was more effective but more costly than community care and more cost-effective than combination treatment and behavioral treatment alone. Under some conditions, combination treatment (medical management and psychotherapy) were somewhat more cost-effective, as demonstrated by lower costs per additional child "normalized" among children with multiple comorbid disorders. CONCLUSIONS: Medical management treatment, although not as effective as combined medical management and behavioral treatment, is likely to be more cost-effective in routine treatment for children with ADHD, particularly those without comorbid disorders. For some children with comorbid disorders, it may be cost-effective to provide combination treatment.
Author information
Author/s: Jensen, Peter S (PS); Garcia, Joe Albert (JA); Glied, Sherry (S); Crowe, Maura (M); Foster, Mike (M); Schlander, Michael (M); Hinshaw, Stephen (S); Vitiello, Benedetto (B); Arnold, L Eugene (LE); Elliott, Glen (G); Hechtman, Lily (L); Newcorn, Jeffrey H (JH); Pelham, William E (WE); Swanson, James (J); Wells, Karen (K);
Affiliation: Center for the Advancement of Children's Mental Health, Department of Child Psychiatry, New York State Psychiatric Institute, Columbia University, 1051 Riverside Dr., Suite 78, New York, NY 10032, USA. pj131(-atsign-)columbia.edu
Grants: UO1 MH-50440 (Agency:NIMH NIH HHS) ; UO1 MH-50447 (Agency:NIMH NIH HHS) ; UO1 MH-50453 (Agency:NIMH NIH HHS) ; UO1 MH-50454 (Agency:NIMH NIH HHS) ; UO1 MH-50461 (Agency:NIMH NIH HHS) ; UO1 MH-50467 (Agency:NIMH NIH HHS)
Journal and publication information
Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
Journal: The American journal of psychiatry (Am J Psychiatry), published in United States. (Language: eng)
Reference: 2005-Sep; vol 162 (issue 9) : pp 1628-36
Dates: Created 2005/09/01; Completed 2005/11/10; Revised 2007/11/14;
PMID: 16135621, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis.
30 Oct 2001 - [The costs of drugs against ADDH should be reduced]
24 Jun 2003 - A modeled economic evaluation comparing atomoxetine with stimulant therapy in the treatment of children with attention-deficit/hyperactivity disorder in the United Kingdom.
29 Apr 2008 - Treatment for ADHD: is more complex treatment cost-effective for more complex cases?
30 Jan 2007 - Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorder.
30 Jul 2004 - Update on drugs for hyperactivity in childhood.
29 Apr 2007 - Long-acting medications for the hyperkinetic disorders. A note on cost-effectiveness.
29 Sep 2007 - A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.
29 Nov 1999 - Sociodemographic and economic comparisons of children prescribed longer-acting versus short-acting stimulant medications for attention deficit hyperactivity disorder.
29 Sep 2005 - [Methylphenidate of retard forms in children and adolescents with ADHD - an overview]
19 Dec 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.